[TO BE PUBLISHED IN THE GAZETTE OF INDIA EXTRAORDINARY PART-II, SECTION-3, SUB-SECTION (ii)]
GOVERNMENT OF INDIA
MINISTRY OF COMMERCE AND INDUSTRY
DEPARTMENT OF COMMERCE
DIRECTORATE GENERAL OF FOREIGN TRADE
[Issued from File No.01/91/180/24/AM22/EC/E-27724]
NOTIFICATION NO 07/2015-2020; Dated: June 01, 2021
Subject: Amendment in Export Policy of Amphotericin-B
In exercise of powers conferred by Section 3 of the Foreign Trade (Development & Regulation) Act, 1992 (No.22 of 1992), as amended, read with Para 1.02 and 2.01 of the Foreign Trade Policy, 2015-20, the Central Government hereby makes the following amendment in Schedule 2 of the ITC (HS) Export Policy, 2018 related to export of Amphotericin B injections:
|S.No.||ITC HS codes||Description||Present Policy||Revised Policy|
2. The provision under Para 1.05 of the Foreign Trade Policy (FTP) 2015-20 regarding transitional arrangement is not applicable for this notification.
3. Effect of this Notification:
The export of Amphotericin-B injections falling under the ITCHS Codes specified above or falling under any other HS Code is restricted, with immediate effect.
Director General of Foreign Trade
Ex-Officio Additional Secretary, Government of India